To study the role of Eomes in IL33-driven antitumor immunity, we implanted B16 and B16-IL33 tumor cells into control and CD4cre Eomesflox/flox mice (EKO) (Figures 2A,B). The gene discussed is IL33; the disease is neoplasm.